DiaMedica Therapeutics Inc.

NASDAQ:DMAC

Biotechnology

Healthcare
$8.59 -0.17%

-$0.01 today

Market cap
$463.49M
Beta
1.00
P/E (TTM)
-8.8
EPS (TTM)
-$0.65
52W Low $3.48High $10.42

Volume 0.21M

Average 0.19M

Balance Sheet

Inspect the capital base behind the business.

Assets

$61.37M

FY 2025 · Annual

+32.4% YoY

Liabilities

$5.26M

FY 2025 · Annual

-6.5% YoY

Equity

$56.11M

FY 2025 · Annual

+37.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents4.71M4.73M4.54M3.03M15.65M
Short-term Investments40.41M28.77M48.35M41.12M44.24M
Net Receivables082K369K236K258K
Inventory00000
Other Current Assets243K00227K481K
Total Current Assets45.44M33.84M53.68M44.61M60.63M
Property, Plant & Equipment (Net)112K560K485K427K342K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0001.31M400K
Total Non-current Assets112K560K485K1.74M742K
Total Assets45.55M34.4M54.16M46.35M61.37M
Account Payables509K734K926K940K1.48M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities484K667K766K1.06M1.38M
Total Current Liabilities1.52M2.17M2.79M5.39M5.13M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities3K400K317K237K128K
Total Liabilities1.53M2.57M3.1M5.63M5.26M
Common Stock00000
Retained Earnings(82.5M)(96.18M)(115.56M)(140M)(172.77M)
Accumulated OCI(51K)(74K)6K23K50K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity44.02M31.83M51.06M40.72M56.11M
Total Debt52K469K400K340K240K
Net Debt(4.66M)(4.26M)(4.14M)(2.69M)(15.41M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$4.9M
Short-term Investments$46.5M
Other Current$1.0M
Total Current Assets$52.4M
PP&E (Net)$317.0K
Other Non-current$400.0K
Total Non-current Assets$717.0K
Total Assets$53.1M

Analysis

Selected assets total $53.1M for Latest. The largest visible component is Short-term Investments at $46.5M, about 87.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipAug 12, 2026
S-8S-8 filingAug 11, 2026
10-QQuarterly reportAug 10, 2026

How much cash does DMAC have?

DiaMedica Therapeutics Inc. (DMAC) reported $15.65M in cash and equivalents in fiscal 2025.

How much debt does DMAC carry?

DiaMedica Therapeutics Inc. (DMAC) reported $240,000.00 of total debt, with net debt of -$15.41M.